CoChat

Ginger Does Not Prevent Postoperative Nausea and Vomiting After Laparoscopic Surgery

Eberhart, Leopold H. J., Mayer, Roswitha, Betz, Oliver, Tsolakidis, Stergios, Hilpert, Wolfgang, Morin, Astrid M., Geldner, G??tz, Wulf, Hinnerk, Seeling, Wulf · 2003 · Anesthesia & Analgesia
Cited by 80

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Ginger (Zingiber officinale) has traditionally been used in China for gastrointestinal symptoms, including nausea and vomiting. As a part of oral premedication, ginger might be especially valuable, because it is inexpensive, lacks known relevant side effects (e.g., sedation), and has a high patient acceptance, because it is part of complementary medicine and is perceived by the public as “natural” and therefore safe (1). Gingerly, especially 8-gingerol, enhances gastrointestinal transport in an animal model (2). Eight-gingerol is a functional antagonist at ileal 5-hydroxytryptamine receptors (3). The subtype 5-hydroxytryptamine type 3 receptor has an important role in the etiology of postoperative nausea and vomiting (PONV) (4). Ernst and Pittler (5) systematically reviewed trials investigating the antiemetic effect of ginger (Zingiber officinale). They performed a metaanalysis of three available studies investigating the herbal remedy in preventing PONV and further critically reviewed another three trials for nausea and vomiting of other conditions. They concluded that ginger was a promising antiemetic, but the clinical data were insufficient to draw firm conclusions. Thus, they called for further rigorous studies to establish whether ginger is effective for nausea and vomiting. In this context, this randomized, placebo-controlled trial was performed to gain further data on the antiemetic properties of the herbal remedy and to evaluate effects on postoperative patient satisfaction. Methods A total of 184 healthy, consenting women undergoing gynecologic laparoscopies were included in this randomized, placebo-controlled trial that was approved by the local ethics committee. They were randomly allocated to one of the following three treatment groups using computer-generated permuted blocks. This list was not broken before patient recruitment and validation of the data were completed. 1) placebo group: 3 × 2 placebo capsules (2 capsules preoperatively as well as 3 and 6 h postoperatively), 2) G300 group: 3 × 1 verum capsules and 3 × 1 placebo capsules (1 capsule preoperatively as well as 3 and 6 h postoperatively) (= 300 mg of ginger extract); and 3) G600 group: 3 × 2 verum capsules (2 capsules preoperatively as well as 3 and 6 h postoperatively) (= 600 mg of ginger extract). One verum capsule contained 100 mg of standardized extract of the rhizome of Zingiber officinale (drug extract ratio 10–20:1; extraction agent: acetone). The gelatin capsules were aromatized with mint flavor to make the ginger and the identically looking placebo capsule indistinguishable with regard to smell and taste. These efforts were made because ginger can be smelled and tasted even when covered with a cellulose-microcrystalline (6). All patients were orally premedicated with 20 mg of clorazepate. General anesthesia was induced with propofol, fentanyl (2 μg/kg), atracurium (0.3–0.5 mg/kg), and in some patients (n = 33), with shorter surgical procedures with succinylcholine (1–2 mg/kg). Desflurane (3–6 vol%) in nitrous oxide/oxygen (Fio2: 0.3) and additional fentanyl were used for maintenance. Fluid administration was standardized. Neuromuscular blockade was antagonized with pyridostigmine (0.1 mg/kg) and atropine (0.5 mg) when clinically indicated (n = 16). No additional antiemetics were applied. Postoperatively, pain was treated with repeated small doses of an opioid (piritramid 2–3 mg) until the patient had reached a level of no or mild pain. If a patient requested therapy for PONV or experienced nausea for at least 10 min or had ≥2 emetic episodes, rescue therapy for PONV was given (0.75–1 mg of droperidol, followed by 2 mg of tropisetron, if ineffective). Patients were visited 1, 3, 6, and 24 h postoperatively. Patients who were operated on a day-case basis were not discharged before the 6-h observation point and contacted 24 h postoperatively by telephone. Patients were asked to rate nausea and postoperative pain since the last visit using a four-point verbal rating scale (none, mild, moderate, severe) and to quantify the episodes of emetic symptoms (vomiting or retching). Twenty-four hours postoperatively, the Quality of Recovery score (7,8) was assessed during a standardized postoperative interview. Patients were also asked to grade their satisfaction using a six-step grading scale (1 = very good, 2 = good, …, 6 = unsatisfactory). A prospective power analysis assumed an incidence rate of PONV in the placebo group of 0.50 (9) and incidence rates of 0.4 and 0.3 in the G300 and G600 groups, respectively. Three hundred sixty patients provide a 90% chance of detecting a significant effect (α = 0.05) using the Cochran Armitage test. Because of the uncertainty with respect to the efficacy and dose responsiveness, an adaptive interim analysis (10) was prospectively planned after half of the foreseen number of patients (n = 180). This design allows stopping the study in case of a significant reduction of the PONV incidence for the veru

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1213/01.ane.0000055818.64084.41

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 80

Metadata

Authors
Eberhart, L. H. J., Mayer, R., Betz, O., Tsolakidis, S., Hilpert, W., Morin, A. M., Geldner, G., Wulf, H., & Seeling, W.
Venue
Anesthesia & Analgesia
Published
2003-04
Volume
96
Issue
4
Pages
995-998
ISSN
0003-2999 (ISSN-L)
OpenAlex
W2002036860
Cited by
80
References
1
FWCI
5.01
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ginger Does Not Prevent Postoperative Nausea and Vomiting After Laparoscopic Surgery. https://app.cochat.ai/papers/10.1213/01.ane.0000055818.64084.41
The paper
Eberhart, L. H. J., Mayer, R., Betz, O., Tsolakidis, S., Hilpert, W., Morin, A. M., Geldner, G., Wulf, H., & Seeling, W. (2003). Ginger Does Not Prevent Postoperative Nausea and Vomiting After Laparoscopic Surgery. Anesthesia & Analgesia. https://doi.org/10.1213/01.ane.0000055818.64084.41

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.